Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation*

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Critical Care Medicine

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.CCM.0000166370.94927.B6PMID 15942357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug intervention trials in sepsis: divergent results.

  2004cited by this paper
• Disseminated intravascular coagulation.

  2003cited by this paper
• Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

  2003cited by this paper
• Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia.

  2003cited by this paper
• Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor

  2003cited by this paper
• The Impact of Heparin Compounds on Cellular Inflammatory Responses: A Construct for Future Investigation and Pharmaceutical Development

  2003influential reference
• [Disseminated intravascular coagulation].

  2003cited by this paper
• Low-dose heparin for severe sepsis.

  2003cited by this paper
• Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia

  2003cited by this paper
• Low-dose heparin for severe sepsis.

  2002cited by this paper
• Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model

  2002cited by this paper
• Tissue factor activity in human monocytes is regulated by plasma: implications for the high and low responder phenomenon

  2001cited by this paper
• Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

  2001cited by this paper
• Depletion of Plasma Factor XIII Prevents Disseminated Intravascular Coagulation-induced Organ Damage

  2001cited by this paper
• High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• In vivo natural killer cell activities revealed by natural killer cell-deficient mice.

  2000cited by this paper
• Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease

  2000cited by this paper
• Expression of Fas and Fas Ligand on Mouse Renal Tubular Epithelial Cells in the Generalized Shwartzman Reaction and Its Relationship to Apoptosis

  1999cited by this paper
• Disseminated Intravascular Coagulation

  1999cited by this paper
• Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells.

  1998cited by this paper
• LOW MOLECULAR WEIGHT HEPARIN PREVENTS THE PULMONARY HEMODYNAMIC AND PATHOMORPHOLOGIC EFFECTS OF ENDOTOXIN IN A PORCINE ACUTE LUNG INJURY MODEL

  1998cited by this paper
• Apoptotic cell death of vascular endothelial cells and renal tubular cells in the generalized Shwartzman reaction.

  1996cited by this paper
• Rheumatoid arthritis and heparin.

  1996cited by this paper
• Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects.

  1993cited by this paper
• Dextran sulfate and heparin sulfate inhibit platelet-activating factor-induced pulmonary edema.

  1992cited by this paper
• Semisolid solidification of high temperature superconducting oxides

  1992cited by this paper
• E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro.

  1992cited by this paper
• DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.

  1991cited by this paper
• STUDIES ON THE GENERALIZED SHWARTZMAN REACTION

  1952cited by this paper

• Network pharmacology- and molecular simulation-based exploration of therapeutic targets and mechanisms of heparin for the treatment of sepsis/COVID-19

  2023cites this paper
• Effect of anticoagulant and platelet inhibition on the risk of bacteremia among patients with acute pyelonephritis: a retrospective cohort study

  2022cites this paper
• TRPC channels blockade abolishes endotoxemic cardiac dysfunction by hampering intracellular inflammation and Ca2+ leakage

  2022cites this paper
• Role of lungs in the hemostasis system (review of literature).

  2021cites this paper
• Paeoniflorin alleviates lipopolysaccharide‐induced disseminated intravascular coagulation by inhibiting inflammation and coagulation activation

  2020cites this paper
• Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis.

  2020cites this paper
• Using heparin molecules to manage COVID‐2019

  2020cites this paper
• NIR Fluorescent Nanoprobes and Techniques for Brain Imaging

  2020cites this paper
• Near Infrared-Emitting Nanoparticles for Biomedical Applications

  2020cites this paper
• Coagulation Abnormalities in Sepsis

  2019cites this paper
• Genistein has the function of alleviating and treating disseminated intravascular coagulation caused by lipopolysaccharide

  2018cites this paper
• Withanolides against TLR4‐Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study

  2017cites this paper
• Heparin-Binding Protein (HBP): A Causative Marker and Potential Target for Heparin Treatment of Human Sepsis-Induced Acute Kidney Injury

  2017cites this paper
• Near-Infrared Emitting PbS Quantum Dots for in Vivo Fluorescence Imaging of the Thrombotic State in Septic Mouse Brain

  2016cites this paper
• Low molecular weight heparin prevents lipopolysaccharide induced-hippocampus-dependent cognitive impairments in mice.

  2015cites this paper
• Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome

  2013cites this paper
• Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome – a retrospective propensity matched cohort study

  2012cites this paper
• Targeting the coagulation factor fibrinogen for arthritis therapy.

  2011cites this paper
• The effect of heparin administration in animal models of sepsis: A prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies*

  2011cites this paper
• Animal models of DIC and their relevance to human DIC: a systematic review.

  2011cites this paper
• Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice.

  2011cites this paper
• Venous sinus thrombosis and consumptive coagulopathy: a role for heparin?

  2010cites this paper
• Acute Disseminated Intravascular Coagulation

  2009cites this paper
• Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of tumor cells.

  2009cites this paper
• ENOXAPARIN ATTENUATES ENDOTHELIAL DAMAGE WITH LESS BLEEDING COMPARED WITH UNFRACTIONATED HEPARIN IN ENDOTOXEMIC RATS

  2009cites this paper
• IJPP Hemotology 9-2-08

  2009cites this paper
• Carbon monoxide releasing molecules: New insights for anticoagulation strategy in sepsis

  2009cites this paper
• Nafamostat prevents hypothermia and improves survival time after administration of lipopolysaccharide in a mouse surgical model

  2009influential citation
• Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats

  2008cites this paper
• Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats*

  2008cites this paper
• Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures.

  2008cites this paper
• Hematological and Coagulation Changes in Sepsis

  2008cites this paper
• The Role of Bronchoalveolar Hemostasis in the Pathogenesis of Acute Lung Injury

  2008cites this paper
• Coagulation and anticoagulation in acute lung injury, pneumonia, and ventilator-associated lung injury

  2007cites this paper
• Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation.

  2007cites this paper
• Coagulation in Sepsis

  2007cites this paper
• Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats

  2007cites this paper
• Non‐hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia

  2007cites this paper
• Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation

  2007cites this paper
• The role of heparin and allied compounds in the treatment of sepsis

  2007cites this paper
• The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock

  2007cites this paper
• Hematologic disorders in critically ill patients.

  2006cites this paper
• Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation

  2006cites this paper
• Hematologic Disorders in Critically Ill Patients

  2006cites this paper
• Blood transfusion and the development of acute respiratory distress syndrome: More evidence that blood transfusion in the intensive care unit may not be benign*

  2005cites this paper
• Blood transfusion and the development of acute respiratory distress syndrome: more evidence that blood transfusion in the intensive care unit may not be benign.

  2005cites this paper
• Heparins in sepsis-induced disseminated intravascular coagulation: low weight-high impact?

  2005cites this paper